Logo
Home
Company ProfileBoards & StaffsMemberships & PartnersAcademy of JournalismCareersBlog(EN)Contact Us
Our JournalsInstruction for AuthorsBrieflands PoliciesPublish My ResearchJournal Management SystemArticle Processing ChargesOpen Peer ReviewPublishing Services
Publish My Book
  1. Brieflands
  2. journals
  3. Jundishapur Journal of Natural Pharmaceutical Products
  4. Articles

  5. Efficacy of N-acetyl Cysteine in Severe COVID-19 Patients: A Randomized Controlled Phase III Clinical Trial
  6. Scopus by Title (Ref)

Jundishapur Journal of Natural Pharmaceutical Products

The Official Journal of Ahvaz Jundishapur University of Medical Sciences

Home
Current IssueAccepted ManuscriptsAll IssuesIn PressSearch
Instructions
Journal InformationBoard & CommitteeIndexing and Listing SourcesJournal MetricsOpen Peer Review (OPR)Publication Ethics and Malpractice StatementReviewer and AE Registration FormJoin JJNPP EditorialSupportContact Us
APC
Authors GuideSubmit Manuscript

Scopus by Title (Ref)


1. Natural Substances in the Management of Coronavirus Disease 2019 Infection

- Lucius K. , et al.

2. High-dose Intravenous N-Acetylcysteine in Mechanically Ventilated Patients with COVID-19 Pneumonia: A Propensity-Score Matched Cohort Study

- Fong K.M. , et al.

3. COVID-19 clinical outcomes and N-acetylcysteine (CoViNAC study): a GRADE compliant meta-analysis of randomized controlled trials with molecular docking and dynamics simulation studies with Mpro of SARS-CoV-2

- Varikasuvu S.R. , et al.

HomeInstructionsAPC

Archives

  • Current Issue
  • Accepted Manuscripts
  • All Issues
  • In Press
  • Search

About Journal

  • Journal Information
  • Board & Committee
  • Indexing and Listing Sources
  • Journal Metrics
  • Open Peer Review (OPR)
  • Publication Ethics and Malpractice Statement
  • Reviewer and AE Registration Form
  • Join JJNPP Editorial
  • Support
  • Contact Us
Support
Submit a Ticket
BrieflandsBrieflands

Science, Technical, Medical Publisher, Since 2007

All rights reserved by Brieflands, 2026.

Powered by Neoscriber.